KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Capital Employed (2019 - 2025)

BioNTech SE's Return on Capital Employed history spans 7 years, with the latest figure at 6.85% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 28.0% to 6.85% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.85%, a 28.0% decrease, with the full-year FY2025 number at 7.2%, down 74.0% from a year prior.
  • Return on Capital Employed hit 6.85% in Q4 2025 for BioNTech SE, down from 4.63% in the prior quarter.
  • Over the last five years, Return on Capital Employed for BNTX hit a ceiling of 12460520.5% in Q1 2021 and a floor of 6.85% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 1146096.06% across 5 years, with a median of 21.27% in 2023.
  • The widest YoY moves for Return on Capital Employed: up 1246054706bps in 2021, down -1933158521bps in 2021.
  • Tracing BNTX's Return on Capital Employed over 5 years: stood at 133.74% in 2021, then tumbled by -50bps to 66.34% in 2022, then crashed by -95bps to 3.3% in 2023, then tumbled by -299bps to 6.57% in 2024, then dropped by -4bps to 6.85% in 2025.
  • Business Quant data shows Return on Capital Employed for BNTX at 6.85% in Q4 2025, 4.63% in Q3 2025, and 4.5% in Q2 2025.